Poster featuring TILT technology will be presented at the European Society of Cell and Gene Therapy Annual Congress in Florence, Italy in October 2016.
A fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy
Latest News
Upcoming Events
Please contact our business development team to meet us at the following events:
13th November 2023
Investival Showcase 2023
London, England
6-8th December 2023
ESMO IO
Geneva, Switzerland
8-10th January 2024
Biotech Showcase
San Francisco, USA
28-29th February 2024
Sachs Annual European Life Sciences CEO Forum
Zurich, Switzerland
10-12 March 2024
SITC
Miami, USA
18-20th March 2024
BIO-Europe
Barcelona, Spain